Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles & Cell-Free RNAs 2023

Extracellular Vesicles & Cell-Free RNAs 2023



Conference Chairmen

Michael Graner

Michael Graner
Professor, University of Colorado Anschutz School of Medicine

Terry Morgan

Terry Morgan
Professor, Oregon Health and Science University

Keynote Speakers


Larry Chamley
Professor and Head of Department of Obstetrics and Gynaecology, University of Auckland


Daniel Chiu
A. Bruce Montgomery Professor of Chemistry, University of Washington


Brian Eliceiri
Professor, UC San Diego


Leyla Esfandiari
Associate Professor of Biomedical Engineering, University of Cincinnati


Jennifer Jones
NIH Stadtman Investigator, Head of Transnational Nanobiology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute


Andrea Raymond
Associate Professor, Herbert Wertheim College of Medicine, Florida International University


Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas


Shannon Stott
Assistant Professor, Massachusetts General Hospital & Harvard Medical School


Danilo Tagle
Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS)


Shuichi Takayama
Professor, Georgia Research Alliance Eminent Scholar, and Price Gilbert, Jr. Chair in Regenerative Engineering and Medicine Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology & Emory University School of Medicine


Kendall Van Keuren-Jensen
Professor and Deputy Director, Translational Genomics Research Institute

Overview

Welcome to the SelectBIO Extracellular Vesicles & Cell-Free RNAs: Technologies Driving Biological Investigations 2023 Conference to be held in-person on-site in beautiful Laguna Hills, California.

Bringing together researchers and industry participants from both academia and industry, this established event, will discuss the latest innovations and developments in EV/Exosomes fields from a Technology Development and Utilization Perspective.
There is an Extensive International Perspective at this Conference with Speakers, Poster Presenters, Sponsors, and Exhibitors from the US, Europe, and Asia/Pacific. Running alongside the conference will be an exhibition covering the latest technological advances and associated products and services from leading solution providers within this expanding field from around the world.

Registered delegates will have full access to the co-located and concurrent tracks and sessions to mix-and-match presentations and maximize networking:
  • Lab-on-a-Chip and Microfluidics: Techologies, Companies and Commercialization 2023
  • Tools for Developing Point-of-Care & Rapid Diagnostics 2023
  • Extracellular Vesicles (EVs) & Cell-Free RNAs: Technologies Driving Biological Investigations 2023
There is an extensive exhibit hall featuring companies from these fields enabling business development, partnering and networking. Extensive networking opportunities for partnering, collaborations and business development available over the course of this 2.5-day in-person conference with onsite breakfasts, lunches, beer and wine and dinner receptions.


Download Conference Consolidated Agenda PDF at the PDF Thumbnail Below:


Agenda Topics

  • Downstream Analysis of Biomarker Cargo Contained in Extracellular Vesicles (EVs)/Exosomes
  • Extracellular Vesicles and Stem Cells -- An Emerging Area of Investigation for Regenerative Medicine
  • Harvesting Biological Value from EVs: Biomarker Potential, Therapeutic Potential & Drug Delivery Applications of EVs
  • Single Cell and Vesicle Studies by Flow Cytometry and Microfluidics
  • Therapeutic, Drug Delivery and Biologics Opportunities for Extracellular Vesicles (EVs)
  • Tools & Technologies for Isolation of Extracellular Vesicles (EVs)/Exosomes

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Distinguished Faculty

Stuart Ibsen, Assistant Professor, The Knight Cancer Institute’s Cancer Early Detection Advanced Research Center (CEDAR), Oregon Health and Science University
Sukhbir Kaur, Staff Scientist, National Cancer Institute, National Institutes of Health


Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks